ES2564672T3 - Nuevas suspensiones de nanocristales bimetálicos de base de oro y platino, procesos de preparación electroquímica de las mismas y usos para las mismas - Google Patents

Nuevas suspensiones de nanocristales bimetálicos de base de oro y platino, procesos de preparación electroquímica de las mismas y usos para las mismas Download PDF

Info

Publication number
ES2564672T3
ES2564672T3 ES12764547.1T ES12764547T ES2564672T3 ES 2564672 T3 ES2564672 T3 ES 2564672T3 ES 12764547 T ES12764547 T ES 12764547T ES 2564672 T3 ES2564672 T3 ES 2564672T3
Authority
ES
Spain
Prior art keywords
platinum
water
approximately
nanocrystals
gold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12764547.1T
Other languages
English (en)
Spanish (es)
Inventor
Adam R. Dorfman
David A. Bryce
Maxwell A. Grace
D. Kyle Pierce
Mikhail Merzliakov
Mark G. Mortenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GR Intellectual Reserve LLC
Original Assignee
GR Intellectual Reserve LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GR Intellectual Reserve LLC filed Critical GR Intellectual Reserve LLC
Application granted granted Critical
Publication of ES2564672T3 publication Critical patent/ES2564672T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • B82B3/0009—Forming specific nanostructures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C30/00—Alloys containing less than 50% by weight of each constituent
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/02—Alloys based on gold
    • C—CHEMISTRY; METALLURGY
    • C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22C—ALLOYS
    • C22C5/00—Alloys based on noble metals
    • C22C5/04—Alloys based on a platinum group metal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Metallurgy (AREA)
  • Mechanical Engineering (AREA)
  • Materials Engineering (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
  • Powder Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
ES12764547.1T 2011-03-30 2012-03-30 Nuevas suspensiones de nanocristales bimetálicos de base de oro y platino, procesos de preparación electroquímica de las mismas y usos para las mismas Active ES2564672T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161469525P 2011-03-30 2011-03-30
US201161469525P 2011-03-30
PCT/US2012/031654 WO2012135743A2 (en) 2011-03-30 2012-03-30 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same

Publications (1)

Publication Number Publication Date
ES2564672T3 true ES2564672T3 (es) 2016-03-28

Family

ID=46932416

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12764547.1T Active ES2564672T3 (es) 2011-03-30 2012-03-30 Nuevas suspensiones de nanocristales bimetálicos de base de oro y platino, procesos de preparación electroquímica de las mismas y usos para las mismas

Country Status (15)

Country Link
US (3) US9387225B2 (enExample)
EP (1) EP2691082B1 (enExample)
JP (1) JP6121985B2 (enExample)
KR (2) KR102103534B1 (enExample)
CN (1) CN103764123B (enExample)
BR (1) BR112013025112A2 (enExample)
CA (1) CA2829095C (enExample)
DK (1) DK2691082T3 (enExample)
ES (1) ES2564672T3 (enExample)
IL (1) IL228356A (enExample)
MX (1) MX337439B (enExample)
PH (1) PH12013501954A1 (enExample)
RU (1) RU2617055C2 (enExample)
SG (1) SG193439A1 (enExample)
WO (1) WO2012135743A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103757663A (zh) * 2007-07-11 2014-04-30 Gr智力储备股份有限公司 用于处理液体以及在液体中制造某些组分例如纳米粒的连续方法、装置以及获得的纳米粒和纳米粒/液体溶液
EP2735389A1 (de) * 2012-11-23 2014-05-28 Universität Duisburg-Essen Verfahren zur Herstellung reiner, insbesondere kohlenstofffreier Nanopartikel
JP5891320B1 (ja) * 2015-02-12 2016-03-22 秋田県 ゼータ電位制御法を用いた処理方法
CN106680450B (zh) * 2017-03-23 2023-04-25 江西省农业科学院农业经济与信息研究所 水质监测装置及方法
US11674234B1 (en) * 2020-09-30 2023-06-13 National Technology & Engineering Solutions Of Sandia, Llc Electrodeposited platinum-gold alloy
CN112683710B (zh) * 2020-12-02 2024-04-16 大连理工大学 一种氯离子侵蚀下钢筋混凝土桥板加速腐蚀的试验装置
CN112935273A (zh) * 2021-01-26 2021-06-11 哈尔滨理工大学 一种室温制备CuPt合金纳米颗粒的方法
JP2022131579A (ja) 2021-02-26 2022-09-07 キオクシア株式会社 分析装置および分析方法
CN113500199B (zh) * 2021-06-10 2022-11-08 浙江大学 一种基于金铂双金属活性氧自生成纳米材料的制备方法及其产品和应用
CN113777034B (zh) * 2021-08-20 2024-04-19 嘉兴学院 金纳米双锥阵列基底及其制备方法和应用
CN114470201B (zh) * 2021-12-24 2024-03-19 上海市儿童医院 一种装载kcna5抗体的金铂纳米颗粒及其制备方法和应用
CN120504491B (zh) * 2025-07-21 2025-09-16 景德镇学院 一种稳定陶瓷釉料烧制发色的添加剂及其方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5074652B2 (ja) 2000-02-08 2012-11-14 ライスユニバーシティ 治療法および診断法において使用される光学活性なナノ粒子
US7001617B2 (en) * 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6989157B2 (en) 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
JP2002212102A (ja) 2001-01-23 2002-07-31 Ainobekkusu Kk 電気化学的生理活性微粒子
AU2002249046A1 (en) * 2001-04-23 2002-11-05 Nucryst Pharmaceuticals Corp. Lubricious coatings for substrates
WO2005102019A2 (en) * 2004-04-26 2005-11-03 Cap Technologies, Llc Treatment of fluids and/or sludge with electro plasma
TW200704404A (en) * 2005-03-23 2007-02-01 Shetech Co Ltd Precious metal nanocolloid solution
JP2009522099A (ja) * 2006-01-03 2009-06-11 ジーアール インテレクチュアル リザーブ リミティド ライアビリティ カンパニー 液体をより高反応性にする方法及び装置
KR100857389B1 (ko) * 2006-06-30 2008-09-11 (주)아모레퍼시픽 Ap-grr 펩티드 또는 ap-grr 펩티드를 포함하는펩티드사슬 및 이를 포함하는 약물전달담체
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
CN103757663A (zh) 2007-07-11 2014-04-30 Gr智力储备股份有限公司 用于处理液体以及在液体中制造某些组分例如纳米粒的连续方法、装置以及获得的纳米粒和纳米粒/液体溶液
JP2011520769A (ja) * 2007-09-21 2011-07-21 サイトイミューン サイエンシズ インコーポレイテッド ナノ治療コロイド金属組成物および方法
CN102281975B (zh) * 2009-01-15 2015-10-07 Gr智力储备股份有限公司 用于处理液体以及在液体中制造某些组分(例如纳米粒)的连续、半连续和成批方法、装置以及获得的纳米粒和纳米粒/液体溶液和胶体
BR112012000311B1 (pt) * 2009-07-08 2021-12-21 Clene Nanomedicine, Inc. Nanocristais com base em ouro para tratamentos médicos e processos eletroquímicos para a fabricação dos mesmos
KR101090431B1 (ko) * 2009-08-19 2011-12-07 삼성전기주식회사 금속 씨앗을 이용한 금속 나노입자의 제조 방법 및 금속 씨앗을 함유하는 금속 나노입자

Also Published As

Publication number Publication date
KR101955735B1 (ko) 2019-03-07
BR112013025112A2 (pt) 2020-09-29
CN103764123B (zh) 2018-03-13
US20140294963A1 (en) 2014-10-02
DK2691082T3 (en) 2016-02-29
KR20190027933A (ko) 2019-03-15
RU2617055C2 (ru) 2017-04-19
IL228356A (en) 2017-04-30
EP2691082B1 (en) 2016-01-13
CN103764123A (zh) 2014-04-30
CA2829095C (en) 2019-08-27
US20160317578A1 (en) 2016-11-03
CA2829095A1 (en) 2012-10-04
RU2013148011A (ru) 2015-05-10
US9387225B2 (en) 2016-07-12
KR20140020310A (ko) 2014-02-18
SG193439A1 (en) 2013-10-30
PH12013501954A1 (en) 2013-11-25
MX2013011245A (es) 2013-10-17
WO2012135743A2 (en) 2012-10-04
WO2012135743A3 (en) 2014-05-01
JP6121985B2 (ja) 2017-04-26
KR102103534B1 (ko) 2020-04-23
US20230172975A1 (en) 2023-06-08
EP2691082A4 (en) 2015-06-24
JP2014518847A (ja) 2014-08-07
AU2012236213A2 (en) 2014-01-23
MX337439B (es) 2016-03-03
EP2691082A2 (en) 2014-02-05
AU2012236213A1 (en) 2013-11-14
IL228356A0 (en) 2013-12-31
NZ617018A (en) 2015-10-30

Similar Documents

Publication Publication Date Title
US20230172975A1 (en) Gold-Platinum Based Bi-Metallic Nanocrystal Suspensions, Electrochemical Manufacturing Processes Therefor and Uses for the Same
DK2451284T3 (en) NEW GOLD-BASED NANO CRYSTALS FOR MEDICAL TREATMENTS AND ELECTROCHEMICAL PROCESSES FOR PRODUCING THEREOF
AU2018203373B2 (en) Novel gold-based nanocrystals
Sahoo et al. Simultaneous RGB emitting Au nanoclusters in chitosan nanoparticles for anticancer gene theranostics
Zhao et al. Transferrin-directed preparation of red-emitting copper nanoclusters for targeted imaging of transferrin receptor over-expressed cancer cells
Huang et al. Chiral guanosine 5′-monophosphate-capped gold nanoflowers: Controllable synthesis, characterization, surface-enhanced Raman scattering activity, cellular imaging and photothermal therapy
Kumar et al. Advantages and disadvantages of metal nanoparticles
Alshangiti et al. The energetic and physical concept of gold nanorod-dependent fluorescence in cancer treatment and development of new photonic compounds| review
Zhu et al. Galvanic replacement synthesis of multi-branched gold nanocrystals for photothermal cancer therapy
EP3317035A1 (en) Anisotropic particles, methods and uses thereof
AU2012236213B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
NZ617018B2 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
Nuti Engineering Design and Synthesis of Multifunctional Nanoparticles Based on Combinations of Soft and Metallic Materials, and Study of Their Optical, Imaging, and Biological Applications